XML 59 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Investments In Unconsolidated Affiliates - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Jul. 06, 2020
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]              
Investment amount     $ 392,600,000   $ 100,000,000.0 $ 392,600,000  
Equity interests acquired             18.10%
Equity in earnings (losses) of unconsolidated affiliates, net of tax   $ 86,600,000   $ (11,900,000) 66,200,000 (37,900,000)  
Tax on noncash gain   (29,800,000)     (29,800,000)    
Gain on sale of equity investments         5,000,000.0    
Proceeds from sale of equity method investment         8,400,000 0  
Receivable from sale of equity investment, noncurrent   $ 1,800,000     $ 1,800,000    
DNB Investment              
Schedule of Equity Method Investments [Line Items]              
Equity interests acquired 13.00%            
Payments to acquire interest in affiliate $ 100,000,000.0            
Investment acquired (shares) 54,800,000            
Ownership interest (percent) 13.00% 20.00%     20.00%    
Share price (in dollars per share)   $ 25.66     $ 25.66    
Fair value of investment   $ 1,407,500,000     $ 1,407,500,000    
Equity in earnings (losses) of unconsolidated affiliates, net of tax   86,600,000   (11,800,000) 61,200,000 (37,800,000)  
Tax benefit   (29,300,000)   $ 4,200,000 (20,700,000) $ 13,300,000  
Noncash gain as a result of the DNB IPO   $ 88,200,000     $ 88,200,000    
DNB Investment | IPO              
Schedule of Equity Method Investments [Line Items]              
Issuance of stock, IPO (shares) 90,000,000.0            
Price per share (in USD per share) $ 22.00            
Proceeds from issuance of initial public offering $ 2,400,000,000            
DNB Investment | Underwriters' Option              
Schedule of Equity Method Investments [Line Items]              
Issuance of stock, IPO (shares) 11,700,000            
DNB Investment | Private Placement              
Schedule of Equity Method Investments [Line Items]              
Proceeds from issuance of initial public offering $ 400,000,000.0